Next Article in Journal
Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis
Next Article in Special Issue
Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice
Previous Article in Journal
Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties
Previous Article in Special Issue
Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(7), 832; https://doi.org/10.3390/ph15070832
Action Date Notes Link
article xml file uploaded 5 July 2022 08:33 CEST Original file -
article xml uploaded. 5 July 2022 08:33 CEST Update -
article pdf uploaded. 5 July 2022 08:33 CEST Version of Record https://www.mdpi.com/1424-8247/15/7/832/pdf-vor
article html file updated 5 July 2022 08:35 CEST Original file -
article xml file uploaded 6 July 2022 05:12 CEST Update -
article xml uploaded. 6 July 2022 05:12 CEST Update https://www.mdpi.com/1424-8247/15/7/832/xml
article pdf uploaded. 6 July 2022 05:12 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/832/pdf
article html file updated 6 July 2022 05:14 CEST Update -
article html file updated 13 August 2022 00:13 CEST Update https://www.mdpi.com/1424-8247/15/7/832/html
Back to TopTop